A randomized control trial of elective induction at 40 weeks and 41 weeks to prevent prolonged pregnancy. - Trial PACTR202306581858623
Access comprehensive clinical trial information for PACTR202306581858623 through Pure Global AI's free database. This Not Applicable trial is sponsored by IPINNIMO OLUWADARE MARTINS and is currently Recruiting. The study focuses on Obstetrics and Gynecology.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
IPINNIMO OLUWADARE MARTINS
MYSELF
Timeline & Enrollment
Not Applicable
Jan 01, 1900
Jan 01, 1900
Summary
BACKGROUND: Prolonged pregnancy is a major cause of perinatal and maternal morbidity and mortality and also a source of significant anxiety to the pregnant woman and family. Data has shown that the lowest incidence of perinatal morbidity and mortality is between 39 and 40 weeks gestation. A policy of routine induction of labour at 40 weeks could further reduce perinatal mortality and morbidity without increasing maternal anxiety and cesarean section rate . OBJECTIVES: The overall objective of the study is to compare obstetrics and perinatal outcomes of induction of labour at 40 weeks versus 41 weeks in healthy woman with low risk singleton pregnancy.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202306581858623
Non-Device Trial